Transplant or dialysis: What’s the better choice for RCC-induced ESRD patients? A 20-year analysis of OPTN/UNOS data

PURPOSE: The incidence of end-stage renal disease (ESRD) caused by renal cell carcinoma (RCC) is increasing with the high prevalence of RCC as well as those with treatment-related renal function impairment. Worries about tumor recurrence after transplant-related immunosuppression hinder the recommen...

Descripción completa

Detalles Bibliográficos
Autores principales: Hao, Xiaowei, Lai, Wenhui, Xia, Xinze, Xu, Junnan, Wu, Yangyang, Lv, Chao, Lv, Kaikai, Huang, Shuai, Luo, Zhenjun, Meng, Qingyang, Yuan, Qing, Dong, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558276/
https://www.ncbi.nlm.nih.gov/pubmed/36249010
http://dx.doi.org/10.3389/fonc.2022.955771

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558276/
https://www.ncbi.nlm.nih.gov/pubmed/36249010
http://dx.doi.org/10.3389/fonc.2022.955771

Ejemplares similares